Oppenheimer Maintains Outperform on Biomea Fusion, Maintains $70 Price Target

Biomea Fusion, Inc. -2.78%

Biomea Fusion, Inc.

BMEA

10.85

-2.78%

Oppenheimer analyst Hartaj Singh maintains Biomea Fusion (NASDAQ: BMEA) with a Outperform and maintains $70 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via